Through its investment in the American Society of Transplantation (AST), the Fresenius Medical Care Foundation is partnering with AST to survey organ transplant recipients about their experiences with current immunosuppressant agents. Insights gained from the survey will inform strategies to improve patient-reported outcomes.
The survey is designed to pinpoint and address unmet patient needs associated with immunosuppressive medications for people who have undergone organ transplantation. By offering transplant recipients the opportunity to share their experiences with anti-rejection medications, the survey aims to spur patient-centered innovation in immunosuppressive treatments that are centered around the patient's perspective.
